Product
177Lu-LNC1011
1 clinical trial
1 indication
Clinical trial
Phase 1 Trial Assessing Safety, Maximum Tolerated Dose, and Patient-Specific Dosimetry of [177Lu]Lu-LNC1011 in Metastatic Castration-Resistant ProstateStatus: Recruiting, Estimated PCD: 2024-04-01